Cognitive adaptation training combined with assertive community treatment

Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Cognitive adaptation training combined with assertive community treatment : A randomised longitudinal trial. / Hansen, Jens Peter; Ostergaard, Birte; Nordentoft, Merete; Hounsgaard, Inger Lise.

I: Schizophrenia Research, Bind 135, Nr. 1-3, 2012, s. 105-11.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hansen, JP, Ostergaard, B, Nordentoft, M & Hounsgaard, IL 2012, 'Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial', Schizophrenia Research, bind 135, nr. 1-3, s. 105-11. https://doi.org/10.1016/j.schres.2011.12.014

APA

Hansen, J. P., Ostergaard, B., Nordentoft, M., & Hounsgaard, I. L. (2012). Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial. Schizophrenia Research, 135(1-3), 105-11. https://doi.org/10.1016/j.schres.2011.12.014

Vancouver

Hansen JP, Ostergaard B, Nordentoft M, Hounsgaard IL. Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial. Schizophrenia Research. 2012;135(1-3):105-11. https://doi.org/10.1016/j.schres.2011.12.014

Author

Hansen, Jens Peter ; Ostergaard, Birte ; Nordentoft, Merete ; Hounsgaard, Inger Lise. / Cognitive adaptation training combined with assertive community treatment : A randomised longitudinal trial. I: Schizophrenia Research. 2012 ; Bind 135, Nr. 1-3. s. 105-11.

Bibtex

@article{12ec38ac038647feaf95e39001effdfb,

title = "Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial",

abstract = "Cognitive adaptation training (CAT) targets the adaptive behaviour of patients with schizophrenia and has shown promising results regarding the social aspects of psychosocial treatment. As yet, no reports have appeared on the use of CAT in combination with assertive community treatment (ACT). Our purpose was to evaluate the effect of CAT in comparison with ACT, focusing on social functions (primary outcome), symptoms, relapse, re-hospitalisation, and quality of life of outpatients with schizophrenia.",

author = "Hansen, {Jens Peter} and Birte Ostergaard and Merete Nordentoft and Hounsgaard, {Inger Lise}",

year = "2012",

doi = "10.1016/j.schres.2011.12.014",

language = "English",

volume = "135",

pages = "105--11",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier",

number = "1-3",

}

RIS

TY - JOUR

T1 - Cognitive adaptation training combined with assertive community treatment

T2 - A randomised longitudinal trial

AU - Hansen, Jens Peter

AU - Ostergaard, Birte

AU - Nordentoft, Merete

AU - Hounsgaard, Inger Lise

PY - 2012

Y1 - 2012

N2 - Cognitive adaptation training (CAT) targets the adaptive behaviour of patients with schizophrenia and has shown promising results regarding the social aspects of psychosocial treatment. As yet, no reports have appeared on the use of CAT in combination with assertive community treatment (ACT). Our purpose was to evaluate the effect of CAT in comparison with ACT, focusing on social functions (primary outcome), symptoms, relapse, re-hospitalisation, and quality of life of outpatients with schizophrenia.

AB - Cognitive adaptation training (CAT) targets the adaptive behaviour of patients with schizophrenia and has shown promising results regarding the social aspects of psychosocial treatment. As yet, no reports have appeared on the use of CAT in combination with assertive community treatment (ACT). Our purpose was to evaluate the effect of CAT in comparison with ACT, focusing on social functions (primary outcome), symptoms, relapse, re-hospitalisation, and quality of life of outpatients with schizophrenia.

U2 - 10.1016/j.schres.2011.12.014

DO - 10.1016/j.schres.2011.12.014

M3 - Journal article

C2 - 22264599

VL - 135

SP - 105

EP - 111

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -

ID: 40183491